Analysis of Bankruptcy Prediction in State-Owned Enter-prises in the Pharmaceuticals Sector
DOI:
https://doi.org/10.70062/harmonieconomics.v2i4.436Keywords:
Bankruptcy, Grover Model, Springate Model, State-Owned Enterprises, Zmijewski ModelAbstract
Operational performance of two state-owned pharmaceutical companies has been in the public spotlight in recent years. Poor financial conditions have caused both companies to experience net losses for years. The risk of bankruptcy becomes a serious threat if the fundamental problems of these two state-owned pharmaceutical companies are not successfully addressed. This study was conducted to determine whether PT. Kimia Farma Tbk and PT. Indofarma Tbk are likely to go bankrupt between 2021-2024 and to analyze the factors that could lead to bankruptcy. This study used a descriptive quantitative approach. Data were analyzed using Springate, Grover, and Zmijewski models to detect bankruptcy. Springate model predicted PT. Kimia Farma Tbk would be in the bankruptcy category from 2021-2024. Grover and Zmijewski model analysis showed that PT. Kimia Farma Tbk was in the healthy category from 2021-2022, then entered the bankruptcy category from 2023-2024. The potential for bankruptcy is influenced by poor liquidity, the company's reliance on debt to finance assets, unproductive asset management, and net losses. The condition of PT. Indofarma Tbk is categorized as bankrupt from 2021-2024 based on the Zmijewski and Springate models. The Grover model predicts PT. Indofarma Tbk will be healthy in 2021 and will then go bankrupt in 2022-2024. Indications of bankruptcy are influenced by declining sales and assets, debt exceeding assets, liquidity difficulties, and a continuing trend of losses.
References
Abadi, M. T., & Misidawati, D. N. (2023). Prediksi kebangkrutan perusahaan (teori, metode, implementasi). Zahir Publishing.
Aini, R. F. N., Erlina, Idris, A., & Ayuanti, R. N. (2024). Analisis prediksi kebangkrutan menggunakan metode Altman Z-score. Competitive: Jurnal Akuntansi dan Keuangan, 6(1), 153–161. https://doi.org/10.31000/competitive.v6i1.4940
Azizah, F. N., & Lastanti, H. S. (2022). Analisis kebangkrutan perusahaan farmasi di Bursa Efek Indonesia periode 2016–2020 dengan menggunakan model Altman Z-score. Jurnal Ekonomi Trisakti, 2(2), 1357–1364. https://doi.org/10.25105/jet.v2i2.14831
Daryani, R. K., & Herdina, N. (2023). Mengevaluasi prediksi kebangkrutan melalui analisis rasio keuangan dan metode Altman Z-score pada perusahaan farmasi tahun 2019–2022. Jurnal Bisnis dan Ekonomi, 1(2), 117–134. https://doi.org/10.61597/jbe-ogzrp.v1i2.8
Dewi, R. P., & Mulsih, A. (2023). Analisis tingkat financial distress menggunakan metode Springate dan Grover pada PT Kalbe Farma Tbk periode 2018–2022. Innovative: Journal of Social Science Research, 3(4), 1013–1017.
Fitriani, L., Rininda, B. P., Fitriyani, Y., & Bandi, M. H. (2025). Analisis prediksi kebangkrutan menggunakan metode Altman Z-score dan Zmijewski pada PT Indofarma Tbk. Jurnal Ilmiah Manajemen, Ekonomi Bisnis, Kewirausahaan, 12(2). https://doi.org/10.30640/ekonomika45.v12i2.3461
Jessica, R. L., Kusumawardani, M. R., & Nadhiroh, U. (2022). Analisis prediksi kebangkrutan berdasarkan metode Altman Z-score pada perusahaan farmasi yang terdaftar di Bursa Efek Indonesia periode 2016–2019. Gemilang: Jurnal Manajemen dan Akuntansi, 2(4), 164–177. https://doi.org/10.56910/gemilang.v2i4.179
Kusmindian, R., & Herdina, D. H. (2023). Mengevaluasi prediksi kebangkrutan melalui analisis rasio keuangan dan metode Altman Z-score pada perusahaan farmasi tahun 2019–2022. Jurnal Bisnis dan Ekonomi, 1(2), 117–134. https://doi.org/10.61597/jbe-ogzrp.v1i2.8
Madewi, A. (2024). Analisis prediksi kebangkrutan menggunakan model Altman Z-score PT Indofarma Tbk tahun 2020–2022. Jurnal Ekonomi dan Bisnis, 1(3), 12–21. https://doi.org/10.63545/economist.v1i3.26
Mangopo, Y. R., Landjang, X. I. S., Wardana, I. E., Edwar, R. C., & Damanik, L. G. S. (2025). Analysis of financial distress using the Altman Z-score model to predict bankruptcy at PT Indofarma Tbk during the period 2022–2024. Inovasi Pembangunan: Jurnal Kelitbangan, 13(2), 1–10. https://doi.org/10.35450/jip.v13i02.1198
Nurezki. (2023). Memprediksi kebangkrutan di PT Indofarma Tbk. Journal of Business Technology and Science, 1(1).
Nurlinda, & Hermuningsih, S. (2023). Analisis kinerja keuangan perusahaan farmasi sebelum dan sesudah pembentukan holding BUMN farmasi. Capital: Jurnal Ekonomi dan Manajemen, 6(2). https://doi.org/10.25273/capital.v6i2.14488
Nurmalina, R., Bandi, M. H., & Hayatie, M. N. (2023). Analisis kebangkrutan menggunakan metode Springate (studi kasus pada PT Garuda Indonesia Tbk tahun 2018–2020). Journal of Economics and Banking, 5(1). https://doi.org/10.35829/econbank.v5i1.286
Siswanto, P. R., & Romadon, S. A. (2021). Analisis prediksi kebangkrutan menggunakan model Altman, Springate, dan Zmijewski pada perusahaan farmasi. Jurnal Akuntansi, Keuangan, Pajak dan Informasi (JAKPI), 1(2), 167–187. https://doi.org/10.32509/jakpi.v1i2.2179
Soleha, A. R. (2022). Analisis laporan keuangan untuk menilai kinerja keuangan PT Kimia Farma Tbk. Jurnal Ecodemica: Jurnal Ekonomi, Manajemen, dan Bisnis, 6(2), 250–260. https://doi.org/10.31294/eco.v6i2.13047
Windayani, S. R., Sulindawati, N. L. G. G., & Devi, S. (2025). Analisis prediksi kebangkrutan dan deteksi kecurangan laporan keuangan pada perusahaan subsektor farmasi dan kesehatan yang terdaftar di BEI periode 2021–2024. Vokasi: Jurnal Riset Akuntansi, 14(3), 1–11. https://doi.org/10.23887/vjra.v14i3.99174
